1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
Prostaglandin D2 release by endometrium and myometrium
Article first published online: 22 AUG 2005
DOI: 10.1111/j.1471-0528.1986.tb07834.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 93, Issue 10, pages 1078–1082, October 1986
Additional Information
How to Cite
REES, M. C.P. and KELLY, R. W. (1986), Prostaglandin D2 release by endometrium and myometrium. BJOG: An International Journal of Obstetrics & Gynaecology, 93: 1078–1082. doi: 10.1111/j.1471-0528.1986.tb07834.x
Publication History
- Issue published online: 22 AUG 2005
- Article first published online: 22 AUG 2005
- Received 13 November 1985, Accepted 6 March 1986
- Abstract
- References
- Cited By
Summary. Prostaglandin D2 (PGD2) release was studied using a super-fusion technique in endometrium and myometrium obtained at hysterectomy from 36 women with measured menstrual blood loss (range 4–840 ml). PGD2 was produced by both tissues with greater rates from endometrium. Cyclical changes in release were found only in the endometrium with increased rates during menstruation and the midluteal phase. In the myometrium the highest release rates were present during menstruation at the start of the superfusion. No significant correlation was found between menstrual blood loss and endometrial or myometrial PGD2 release.